SNNA
Sienna Biopharmaceuticals, Inc.
SNNA
SNNA
Delisted
SNNA was delisted on the 16th of December, 2019.
48 hedge funds and large institutions have $12.3M invested in Sienna Biopharmaceuticals, Inc. in 2019 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 17 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
Holders
48
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$789K | |
| 2 | +$251K | |
| 3 | +$245K | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$79.7K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$60K |
Top Sellers
| 1 | -$2.2M | |
| 2 | -$1.86M | |
| 3 | -$598K | |
| 4 |
State Street
Boston,
Massachusetts
|
-$547K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$123K |